A sweet polydopamine nanoplatform for synergistic combination of targeted chemo-photothermal therapy.

Gao, Yanqin; Wu, Xingjie; Zhou, Linzhu; Su, Yue; Dong, Chang-Ming

Gao, Yanqin; Wu, Xingjie; Zhou, Linzhu; Su, Yue; Dong, Chang-Ming.

Afiliação

Gao Y; Department of Polymer Science and Engineering, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Wu X; Department of Polymer Science and Engineering, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Zhou L; Department of Polymer Science and Engineering, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Su Y; Department of Polymer Science and Engineering, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Dong CM; Department of Polymer Science and Engineering, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.

Macromol Rapid Commun ; 36(10): 916-22, 2015 May.

Article em En | MEDLINE | ID: mdl-25833346

Assuntos

Antibióticos Antineoplásicos/farmacologia; Doxorrubicina/farmacologia; Portadores de Fármacos; Indóis/síntese química; Polímeros/síntese química; Antibióticos Antineoplásicos/química; Sobrevivência Celular/efeitos dos fármacos; Terapia Combinada; Doxorrubicina/química; Composição de Medicamentos; Células HeLa; Células Hep G2; Humanos; Lactose/química; Luz; Terapia com Luz de Baixa Intensidade; Melaninas/química

Palavras-chave

chemo-photothermal therapy; nanomedicines; polydopamine; synergistic effect; targeting effect

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polímeros / Portadores de Fármacos / Doxorrubicina / Indóis / Antibióticos Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google